Login / Signup
Current Advances and Hurdles in Chimeric Antigen Receptor Technology.
Scott McComb
Seung-Hwan Lee
Published in:
Cancers (2020)
Since tumor-specific T cells were first utilized to treat melanoma patients in 1986 [...].
Keyphrases
</>
end stage renal disease
ejection fraction
chronic kidney disease
prognostic factors